Medium-term follow-up of mechanical valves inserted in children

Signe Holm Larsen1, Kim Houlind, Ole Kromann Hansen

  • 1Department of Thoracic and Cardiovascular Surgery, Aarhus University Hospital, Aarhus, Denmark. signe_holm_larsen@hotmail.com

Cardiology in the Young
|November 23, 2006
PubMed

Insights

Mechanical valves can be safely implanted in children, offering acceptable outcomes despite potential complications like heart block. This study highlights good long-term results for pediatric patients receiving mechanical heart valves.

Area of Science:

  • Pediatric Cardiology
  • Cardiovascular Surgery
  • Biomedical Engineering

Background:

  • Mechanical heart valves are crucial for treating pediatric heart conditions.
  • Experience with mechanical valve implantation in children younger than 15 years is limited.
  • Understanding long-term outcomes and complications is essential for clinical decision-making.

Purpose of the Study:

  • To review the experience with mechanical valve implantation in children aged 15 years or younger.
  • To evaluate the mortality, morbidity, and long-term results of these procedures.
  • To assess complications associated with mechanical valves in pediatric patients.

Main Methods:

  • Retrospective review of hospital files for patients who received mechanical valves between 1988 and 2002.
  • Follow-up data collected until March 2005.
  • Analysis of patient demographics, valve position, underlying disease, and clinical outcomes.

Main Results:

  • 41 children received mechanical valves: 27 in atrioventricular position (median age 3.1 years) and 14 in aortic position (median age 13.5 years).
  • Survival rates were 73% up to 16 years (atrioventricular) and 77% up to 13 years (aortic).
  • Complications included heart block requiring pacemakers (22% AV, 7% aortic) and reoperations (19% AV).

Conclusions:

  • Mechanical valves can be implanted in children with acceptable mortality and morbidity.
  • Good long-term results are achievable, although preferably avoided.
  • Careful patient selection and management are crucial for optimizing outcomes in pediatric mechanical valve recipients.
Abstract

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.